PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, open label Phase II Clinical Trial. 30 advanced poorly
differentiated thyroid carcinoma patients who were histopathologically confirmed inoperable
were enrolled in this study.